\u25a0\u539f\u8457\u8ad6\u6587<\/p>\n
1. Matsuo K, Akakabe Y, Kitamura Y, Shimoda Y, Ono K, Ueyama T, Matoba S, Yamada H, Hatakeyama K, Asada Y, Emoto N, Ikeda K. Loss of Apoptosis Regulator through modulating IAP expression (ARIA) Protects Blood Vessels from Atherosclerosis. J Biol Chem. 2015;290:3784-92<\/p>\n
2. Matsuura Y, Yamashita A, Iwakiri T, Sugita C, Okuyama N, Kitamura K, Asada Y. Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity. Thromb Haemost. 2015;114:158-72.<\/p>\n
3. Inoue O, Hokamura K, Shirai T, Osada M, Tsukiji N, Hatakeyama K, Umemura K, Asada Y, Suzuki-Inoue K, Ozaki Y. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis. PLoS One. 2015;10:e0139357.<\/p>\n
4. Moritake H, Obara M, Sameshima N, Asada Y, Komatsu H, Hyakuna N, Sugita K, Ishida Y, Kato M, Tanizawa A, Deguchi T, Imamura T, Kitanaka A, Shimoda K, Kamimura S, Nunoi H. Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia. Int J Hematol. 2015;102:349-56.<\/p>\n
5. Takahashi N, Aoyama F, Ohuchida J, Sameshima N, Asada Y, Sawaguchi A. Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor. Hum Cell. 2015;28:190-8.<\/p>\n
6. Okuyama N, Matsuda S, Yamashita A, Moriguchi-Goto S, Sameshima N, Iwakiri T, Matsuura Y, Sato Y, Asada Y. Human Coronary Thrombus Formation Is Associated With Degree of Plaque Disruption and Expression of Tissue Factor and Hexokinase II. Circ J. 2015;79:2430-8.<\/p>\n
7. Yamada N, Sato Y, Moriguchi-Goto S, Yamashita A, Kodama Y, Sameshima H, Asada Y. Histological severity of fetal inflammation is useful in predicting neonatal outcome. Placenta. 2015;36:1490-3.<\/p>\n
8. \u767d\u6ff1\u5e78\u751f\u3001\u8352\u6b66\u516b\u8d77\u3001\u6e05\u5c71\u548c\u662d\u3001\u67cf\u7530\u5948\u83dc\u3001\u5357\u5d8b\u6d0b\u4e00\u3001\u80a5\u5f8c\u8cb4\u53f2\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6797\u900f\u3001\u6817\u6797\u5fe0\u4fe1. LBC\u6cd5\u306b\u3088\u308b\u5b50\u5bae\u5185\u819c\u7d30\u80de\u8a3a\u306e\u7d30\u80de\u5f62\u614b\u5b66\u7684\u691c\u8a0e\uff1a\u985e\u5185\u819c\u817a\u764c\u3068\u4ed6\u75c5\u5909\u3068\u306e\u6bd4\u8f03. \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u4e5d\u5dde\u9023\u5408\u4f1a\u96d1\u8a8c. 2015; 46:53-59.<\/p>\n
\u25a0\u8457\u66f8<\/p>\n
1. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u30e1\u30f3\u30b1\u30d9\u30eb\u30b0\u786c\u5316\u75c7\u30012431 (2015)\u3001\u533b\u5b66\u5927\u8f9e\u5178 20\u7248, \u5357\u5c71\u5802\uff08\u6771\u4eac\uff09<\/p>\n
2. \u5ca9\u6c5f\u58ee\u4ecb\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a21\u4e16\u7d00\u306e\u7814\u7a76\u3068\u502b\u7406\u300128-32 (2015)\u3001 \u65b0\u30fb\u8840\u6813\u6b62\u8840\u8840\u7ba1\u5b66\uff0d\u8840\u7ba1\u3068\u8840\u5c0f\u677f\uff0d\u3001\u4e00\u702c\u767d\u5e1d\u3001\u4e38\u5c71\u5f81\u90ce\u3001\u5185\u5c71\u771f\u4e00\u90ce\u7de8\u96c6\u3001\u91d1\u82b3\u5802\uff08\u4eac\u90fd\uff09<\/p>\n
3. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u52d5\u8108\u306e\u69cb\u9020\u3068\u52d5\u8108\u786c\u5316\u306e\u75c5\u7406\u300189-85 (2015)\u3001 \u65b0\u30fb\u8840\u6813\u6b62\u8840\u8840\u7ba1\u5b66\uff0d\u8840\u7ba1\u3068\u8840\u5c0f\u677f\uff0d\u3001\u4e00\u702c\u767d\u5e1d\u3001\u4e38\u5c71\u5f81\u90ce\u3001\u5185\u5c71\u771f\u4e00\u90ce\u7de8\u96c6\u3001\u91d1\u82b3\u5802\uff08\u4eac\u90fd\uff09<\/p>\n
4. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u5375\u5de3\u816b\u760d\u306e\u6982\u8981\u3068\u9451\u5225\u75be\u60a3\u3001 291-306 (2015)\u3001\u305d\u306e\u4ed6\u306e\u539f\u767a\u6027\u5375\u5de3\u816b\u760d\u3068\u8ee2\u79fb\u6027\u5375\u5de3\u816b\u760d\u3000\u764c\u8a3a\u7642\u6307\u91dd\u306e\u305f\u3081\u306e\u75c5\u7406\u8a3a\u65ad\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u3000\u5a66\u4eba\u79d1\u816b\u760d\u3000\u9752\u7b39\u514b\u4e4b\u3001\u672c\u5c71\u608c\u4e00\u7de8\u96c6\u3001\u4e2d\u5c71\u66f8\u5e97\uff08\u6771\u4eac\uff09<\/p>\n
5. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u4e2d\u67a2\u795e\u7d4c\u3001130-179 (2015)\u3001\u7d30\u80de\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3000\u7532\u72b6\u817a\u30fb\u5185\u5206\u6ccc\u30fb\u795e\u7d4c\u7cfb\u3000\u7d30\u80de\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u88fd\u59d4\u54e1\u4f1a\u7de8\u96c6\u3001\u91d1\u539f\u51fa\u7248\uff08\u6771\u4eac\uff09<\/p>\n
6. Yamashita A, Asada Y\uff1aPathology and pathophysiology of atherothrombosis: Thrombus growth, vascular thrombogenicity, and plaque metabolism, 1-25 (2015), Thrombosis, atherosclerosis and atherothrombosis: New insights and experimental protocols, Bo?i?-MijovskiM (ed), Intech (Rijeka)<\/p>\n
\u25a0\u7dcf\u8aac<\/p>\n
1. Kuroiwa Y, Yamashita A, Imamura T, Asada Y. Magnetic resonance imaging for qualitative assessment of deep vein thrombosis. Med Imag & Info Sci. 2015; 32: 100-102.<\/p>\n
2. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u9759\u8108\u8840\u6813\u5f62\u6210\u306b\u304a\u3051\u308bXIII\u56e0\u5b50\u3001\u8840\u6db2\u30d5\u30ed\u30f3\u30c6\u30a4\u30a2 25(5): 694-697, 2015<\/p>\n
3. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u5973\u6027\u751f\u6b96\u5668\uff1bPolycystic ovarian disease, \u764c\u8089\u816b\u3001\u30af\u30e9\u30df\u30b8\u30a2\u611f\u67d3\u75c7\u3000\u75c5\u7406\u8a3a\u65ad\u30af\u30a4\u30c3\u30af\u30ea\u30d5\u30a1\u30ec\u30f3\u30b9\u3000\u75c5\u7406\u3068\u81e8\u5e8a\u3000\u81e8\u6642\u5897\u520a\u53f7\u6587\u5149\u5802\uff08\u6771\u4eac\uff09\u30012015;33:192-194.<\/p>\n
4. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u75c5\u7406\u5b66\u7684\u306b\u898b\u305f\u8840\u6813\u75c7\u3001Medicina 2015; 52: 2296-2299.<\/p>\n
5. \u76db\u53e3\u6e05\u9999\u3001\u4e38\u585a\u6d69\u52a9\uff1a\u75c5\u7406\u5b66\u306e\u7acb\u5834\u304b\u3089\u307f\u305fDIC\u306e\u75c5\u614b\u3001\u8840\u6813\u3068\u5faa\u74b02015; 23:19-23<\/p>\n
\u25a0\u305d\u306e\u4ed6<\/p>\n
1. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u30d2\u30c8\u3067\u306e\u52d5\u8108\u786c\u5316\u306e\u6210\u308a\u7acb\u3061\uff0d\u30d7\u30e9\u30fc\u30af\u7834\u7dbb\u3068\u8840\u6813\u5f62\u6210\u306b\u3064\u3044\u3066\u3001Nature Reviews Cardiology \u65e5\u672c\u8a9e\u7248\u30002015<\/p>\n
2. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u8840\u6813\u75c7\u7814\u7a76\u306e\u30d6\u30ec\u30a4\u30af\u30b9\u30eb\u30fc\u3001International Review of Thrombosis\u30002015;10:80<\/p>\n
3. \u5c71\u4e0b\u3000\u7be4\u3001\u68ee\u5cf6\u7fa9\u884c\u3001\u6885\u6751\u548c\u592b\u3001\u6c38\u4e95\u4fe1\u592b\uff1aSPC\u59d4\u54e1\u4f1a\u6d3b\u52d5\u5831\u544a\u3000\u52d5\u7269\u30e2\u30c7\u30eb\u90e8\u4f1a\u3001\u8840\u6813\u6b62\u8840\u8a8c 2015; 26: 454-458.<\/p>\n
\u25a0\u75c7\u4f8b\u5831\u544a<\/p>\n
1. Nakamura E, Sato Y, Moriguchi S, Yamashita A, Higo T, Asada Y. Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination. Case Rep Obstet Gynecol. 2015;2015:690891.<\/p>\n
2. Yamaguchi M, Nishihira K, Okubo T, Asada Y, Kitamura K. Acute renal injury induced by hypersensitivity to tolvaptan in an elderly patient with congestive heart failure. Intern Med. 2015;54:1243-6.<\/p>\n
3. Ishii N, Mochizuki H, Moriguchi-Goto S, Shintaku M, Asada Y, Taniguchi A, Shiomi K, Nakazato M. An autopsy case of elderly-onset acute necrotizing encephalopathy secondary to influenza. J Neurol Sci. 2015;354:129-30.<\/p>\n
4. Kaneko M, Yamauchi A, Yamashita R, Sato Y, Kodama Y, Sameshima H. Did antepartum hypoxic insult caused by fetal vessel thrombosis influence the procalcitonin level in umbilical blood? A case report. J Obstet Gynaecol Res. 2015;41:1839-42.<\/p>\n
5. \u897f\u5ddd\u8a69\u7e54\u3000\u5fb3\u6e80\u8cb4\u5b50\u3000\u91ce\u53e3\u88d5\u53f2\u3000\u9ed2\u6728\u6804\u8f1d\u3000\u5927\u91ce\u62db\u4f38\u3000\u7532\u6590\u771e\u5f18\u3000\u4f50\u85e4\u52c7\u4e00\u90ce
\n\u8d85\u97f3\u6ce2\u5185\u8996\u93e1\u4e0b\u7a7f\u523a\u5438\u5f15Endoscopic ultrasonography-fine needle aspiration (EUS-FNA)\u306e\u7d30\u80de\u8a3a\u691c\u4f53\u306b\u304a\u3044\u3066\u30bb\u30eb\u30d6\u30ed\u30c3\u30af\u6cd5\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f2\u4f8b.\u3000\u533b\u5b66\u691c\u67fb. 2015;5:559-563\uff0e<\/p>\n
6. \u5c0f\u677f\u88d5\u4e4b\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u535c\u90e8\u6d69\u4fca\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u7247\u5ca1\u5bdb\u7ae0. \u5375\u5de3\u985e\u5185\u819c\u5883\u754c\u60aa\u6027\u816b\u760d\u306e1\u4f8b.\u3000\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c. 2015;6: 23-26.<\/p>\n
7. \u843d\u5408\u5f70\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u7530\u4e2d\u5f18\u4e4b\u3001\u76db\u53e3\u6e05\u9999\u3001\u6cb3\u91ce\u5178\u5b50\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u798f\u5cf6\u548c\u5b50\u3001\u5927\u897f\u6df3\u4ec1\u3001\u9bab\u5cf6\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce.\u3000\u5b50\u5bae\u981a\u90e8\u7d68\u6bdb\u817a\u7ba1\u72b6\u817a\u764c\u306bStratified mucin-producing intraepithelial lesion (SMILE)\u3092\u4f34\u3063\u305f1\u4f8b. \u8a3a\u65ad\u75c5\u7406 2016;35:66-69.<\/p>\n
8. \u5927\u897f \u6df3\u4ec1\u3001\u6cb3\u91ce \u5178\u5b50\u3001\u897f\u6751 \u7f8e\u5e06\u5b50\u3001\u798f\u5cf6 \u548c\u5b50\u3001\u5ddd\u8d8a \u9756\u4e4b\u3001\u9bab\u5cf6 \u6d69\u3001\u6c38\u4e95 \u516c\u6d0b\u3001\u4f50\u85e4\u52c7\u4e00\u90ce.\u3000\u5f53\u9662\u306b\u304a\u3051\u308b\u5b50\u5bae\u9838\u90e8\u795e\u7d4c\u5185\u5206\u6ccc\u764c4\u4f8b\u306e\u691c\u8a0e. \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c 2015;39:99-102.<\/p>\n
\u25a0\u5b66\u4f1a<\/p>\n
1. \u76db\u53e3\u6df8\u9999\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u671b\u6708\u4ec1\u5fd7\u3001\u65b0\u5b85\u96c5\u5e78\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u6025\u6027\u58ca\u6b7b\u6027\u8133\u708e\uff08\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8133\u75c7\uff09\u306e1\u5256\u691c\u4f8b\u3001\u7b2c104\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u540d\u53e4\u5c4b\u30014\/30-5\/2, 2015\uff09<\/p>\n
2. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76db\u53e3\u6e05\u9999\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u798f\u5cf6\u3000\u525b\u3001\u6d45\u7530\u7950\u58eb\u90ce. Primitive neuroectodermal tumor (PNET)\u69d8\u6210\u5206\u3068\u795e\u7d4c\u81a0\u816b(glioma)\u6210\u5206\u304c\u307f\u3089\u308c\u305f\u8133\u816b\u760d\u306e2\u4f8b. \u7b2c104\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u540d\u53e4\u5c4b\u30014\/30-5\/2, 2015)<\/p>\n
3. Yamashita A, Asada Y. Determinants of coronary thrombogenicity: Distinct tissue factor activity and lactate production in M1\/M2 polarized macrophages. IXth Aso International Meeting (Aso, May 14-16, 2015)<\/p>\n
4. \u843d\u5408\u6634\u4e00\u90ce\u3001\u6cb3\u91ce\u6587\u5f70\u3001\u7530\u4e2d\u8015\u76db\u3001\u4e2d\u5c3e\u5927\u4f38\u3001\u68ee\u6643\u7950\u3001\u9577\u6ff1\u535a\u5e78\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u4e2d\u6751\u90fd\u82f1: \u76f4\u8178\u795e\u7d4c\u5185\u5206\u6ccc\u7d30\u80de\u764c\u306e\u6cbb\u7642\u7d4c\u9a13. \u7b2c52\u56de\u4e5d\u5dde\u5916\u79d1\u5b66\u4f1a (\u5927\u5206\u5e02\u30015\/8-9, 2015)<\/p>\n
5. \u5c71\u4e0b\u3000\u7be4\u3001\u76db\u53e3\u6e05\u9999\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u51a0\u52d5\u8108\u306e\u8840\u6813\u30b5\u30a4\u30ba\u306b\u95a2\u9023\u3059\u308b\u8840\u7ba1\u6027\u56e0\u5b50\uff1a\u89e3\u7cd6\u7cfb\u4ee3\u8b1d\u3068\u51dd\u56fa\u6d3b\u6027\u306e\u95a2\u9023\u3001\u7b2c37\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u7532\u5e9c\u30015\/21-5\/23, 2015\uff09<\/p>\n
6. \u5c0f\u6c60\u667a\u4e5f\u3001\u30e6\u30a6\u30a4\u30f3\u3001\u5c71\u4e0b \u7be4\u3001\u6c38\u5742\u4eae\u8f14\u3001\u5c71\u7530\u609f\u58eb\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5869\u898b\u96c5\u5fd7:\u3000 WHHLMI\u30a6\u30b5\u30ae\u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u767a\u751f\u30fb\u9032\u5c55\u904e\u7a0b\u306e\u691c\u8a0e.\u3000\u7b2c62\u56de\u65e5\u672c\u5b9f\u9a13\u52d5\u7269\u5b66\u4f1a\u7dcf\u4f1a\u3000(\u4eac\u90fd 5\/28-5\/30, 2015)<\/p>\n
7. Sato Y, Yamashita A, Onishi J, Muraoka J, Fukushima K, Sameshima H, Asada Y.Synchronous endometrioid carcinoma of the uterine corpus and ovary: A case report. The 19th Taiwan-Japan-Korea Joint Conference for Gynecological Pathology, (Nagoya, June 6, 2015)<\/p>\n
8. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u798f\u5cf6\u548c\u5b50\u3001\u9bab\u5cf6\u6d69\u3001\u6728\u4f50\u8cab\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce: \u8853\u4e2d\u8fc5\u901f\u3067\u539f\u767a\u6027\u5375\u5de3\u817a\u764c\u3068\u8a3a\u65ad\u3057\u305f\u8ee2\u79fb\u6027\u5375\u5de3\u816b\u760d\u306e1\u4f8b. \u7b2c42\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a (\u540d\u53e4\u5c4b\u30016\/7, 2015)<\/p>\n
9. \u5fb3\u6e80\u8cb4\u5b50\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5cf0\u677e\u6620\u5b50\u3001\u5927\u91ce\u62db\u4f38\u3001\u795e\u7530\u4fee\u53f8\u3001\u9ed2\u6728\u6804\u8f1d\u3001\u897f\u5ddd\u8a69\u7e54\u3001\u76db\u53e3\u6e05\u9999\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u4f50\u85e4\u4fe1\u4e5f\uff1a\u80c6\u7ba1\u30fb\u81b5\u7ba1\u64e6\u904e\u30d6\u30e9\u30b7\u6d17\u6d44\u6db2\u306e\u5f93\u6765\u6cd5\u3068LBC\u6cd5\u306e\u7d30\u80de\u5b66\u7684\u691c\u8a0e\u3001\u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u671f\u5927\u4f1a\uff08\u677e\u6c5f\u30016\/12-14, 2015\uff09<\/p>\n
10. \u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u5927\u91ce\u62db\u4f38\u3001\u5cf0\u677e\u6620\u5b50\u3001\u9ed2\u6728\u6804\u8f1d\u3001\u897f\u5ddd\u8a69\u7e54\u3001\u76db\u53e3\u6e05\u9999\u3001\u4e38\u585a\u6d69\u52a9\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u30a2\u30ba\u30fc\u30eb\u9846\u7c92\u3092\u6709\u3059\u308b\u4e2d\u67a2\u795e\u7d4c\u7cfb\u539f\u767a B \u7d30\u80de\u6027\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e 1 \u4f8b\u3001\u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u671f\u5927\u4f1a\uff08\u677e\u6c5f\u30016\/12-14, 2015\uff09<\/p>\n
11. \u4f50\u85e4\u52c7\u4e00\u90ce\u3000\u5fb3\u6e80\u8cb4\u5b50\u3000\u5927\u91ce\u62db\u4f38\u3000\u91ce\u53e3\u88d5\u53f2\u3000\u5cf0\u677e\u6620\u5b50\u3000\u897f\u5ddd\u8a69\u7e54\u3000\u9ed2\u6728\u6804\u8f1d\u3001\u795e\u7530\u4fee\u53f8\u3000\u76db\u53e3\u6e05\u9999\u3000\u4f50\u85e4\u4fe1\u4e5f\uff1a\u661f\u7d30\u80de\u7cfb\u4ee5\u5916\u306e\u8133\u816b\u760d\u306b\u304a\u3051\u308b\u7570\u5e38\u8840\u7ba1\u306e\u5f62\u614b\u5b66\u7684\u691c\u8a0e\u3001\u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7dcf\u4f1a\uff08\u677e\u6c5f\u30016\/12-14, 2015\uff09<\/p>\n
12. \u4f50\u3005\u6728 \u60c7\uff0c\u4e2d\u6751\u76f4\u54c9\uff0c\u5e73\u6238\u7d14\u5b50\uff0c\u6e05\u6c34\u79c0\u6a39\uff0c\u4f50\u85e4\u52c7\u4e00\u90ce\uff0c\u4f0a\u53e4\u7530\u52c7\u4eba\uff0c\u4e95\u91ce\u5143\u667a\u6075\uff0c\u4f50\u85e4\u4fe1\u4e5f\uff0c\u6709\u7530\u8302\u5b9f\uff0c\u82b9\u6fa4\u662d\u5f66\u3000\u7d30\u80de\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u89e3\u8aac\u300c\u4e2d\u67a2\u795e\u7d4c\u7cfb\uff0f\u810a\u9ac4\u6db2\u300d\u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u671f\u5927\u4f1a\u3000(\u677e\u6c5f\u30016\/12-14, 2015\uff09<\/p>\n
13. Matsuda S, Yamashita A, Moriguchi-Goto S, Sameshima N, Iwakiri T, Yunosuke Matsuura Y, Sato Y, Asada Y. Pathological determinants of human coronary thrombus formation: distinct procoagulant activity and lactate production of M1\/M2 polarized macrophages. XXV Congress, International Socitety on Thrombosis and Haemostasis, (Toronto, 6\/20-25, 2015)<\/p>\n
14. \u9ed2\u5ca9\u9756\u6df3\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u4e2d\u6751\u3000\u6075\u7406\u5b50\u3001\u5bae\u5730\u3000\u5229\u660e\u3001\u798f\u898b\u3000\u30a2\u30a6\u30a7\u30a4\u30b9\u3001\u798f\u7530\u3000\u3055\u3068\u307f\u3001\u524d\u7530\u3000\u660c\u4e8c\u3001\u6728\u539f\u3000\u5eb7\u3001\u4eca\u6751\u3000\u5353\u90ce\u3001\u6d45\u7530\u3000\u7950\u58eb\u90ce\uff1a\u6df1\u90e8\u9759\u8108\u8840\u6813\u306eMRI\u6240\u898b\uff1a\u7279\u306b\u5668\u8cea\u5316\u306e\u6240\u898b\u3001 \u7b2c80\u56de\u5bae\u5d0e\u653e\u5c04\u7dda\u6280\u8853\u7814\u7a76\u4f1a\uff08\u5bae\u5d0e\u30017\/4\uff0c2015\uff09<\/p>\n
15. \u5c0f\u6c60 \u667a\u4e5f\u3001\u30e6\u30a6 \u30a4\u30f3\u3001\u5c71\u4e0b \u7be4\u3001\u6c38\u5742 \u4eae\u8f14\u3001\u5c71\u7530 \u609f\u58eb\u3001\u6d45\u7530 \u7950\u58eb\u90ce\u3001\u5869\u898b \u96c5\u5fd7: \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u767a\u751f\u30fb\u9032\u5c55\u904e\u7a0b\u306e\u89e3\u660e\uff0dWHHLMI\u30a6\u30b5\u30ae\u306b\u3088\u308b\u89e3\u6790. \u7b2c47\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. 2015\u5e747\u67089-10\u65e5\uff08\u4ed9\u53f0\u30017\/9-10, 2015\uff09<\/p>\n
16. \u76db\u53e3\u6e05\u9999\u3001\u4e38\u585a\u6d69\u52a9\u3001\u5317\u4e2d\u660e\u3001\u4e0b\u7530\u548c\u54c9\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\uff1aCD20\u967d\u6027\u672b\u68a2\u6027T\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e\uff11\u4f8b\u3001\u7b2c55\u56de\u65e5\u672c\u30ea\u30f3\u30d1\u7db2\u5185\u7cfb\u5b66\u4f1a\u7dcf\u4f1a\uff08\u5ca1\u5c71\u30017\/9-11, 2015\uff09<\/p>\n
17. Yamashita A, Matsuura Y, Asada Y\uff1aVascular wall hypoxia promotes arterial thrombus formation. The 3rd Conference of the Japanese Association for hypoxia biology (Tokyo, July 25, 2015)<\/p>\n
18. \u9ed2\u6728\u6804\u8f1d\u3000\u91ce\u53e3\u88d5\u53f2\u3000\u5fb3\u6e80\u8cb4\u5b50\u3000\u795e\u7530\u4fee\u53f8\u3000\u5cf0\u677e\u6620\u5b50\u3000\u897f\u5ddd\u8a69\u7e54\u3000\u5927\u91ce\u62db\u4f38\u3001\u6728\u7530\u548c\u8cb4\u3000\u8cc0\u672c\u654f\u884c\u3000\u524d\u5ddd\u548c\u4e5f\u3000\u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u5c3f\u7d30\u80de\u8a3a\u3067\u5224\u5b9a\u306b\u82e6\u616e\u3057\u305f\u8180\u80f1\u816b\u760d\u306e1\u4f8b\u3001\u7b2c31\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u4e5d\u5dde\u9023\u5408\u4f1a\u5b66\u4f1a\uff08\u9e7f\u5150\u5cf6\u30017\/25-26, 2015\uff09<\/p>\n
19. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u6a2a\u4e0a\u8056\u8cb4\u3001\u658e\u85e4\u6e05\u8cb4\u3001\u7af9\u5cf6\u79c0\u96c4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u7b2c4\u8133\u5ba4\u306b\u767a\u751f\u3057\u305fRosette-forming glioneuronal tumor\u306e1\u4f8b.\u30002015\u5e74\u5ea6\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u5c0f\u5150\u816b\u760d\u75c7\u4f8b\u691c\u8a0e\u4f1a\u3000(\u6771\u4eac\u30018\/28, 2015)<\/p>\n
20. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5c0f\u677f\u88d5\u4e4b\u3001\u5c71\u7530\u76f4\u53f2\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3000\u7b2c4\u8133\u5ba4\u306b\u767a\u751f\u3057\u305fFeto-materna l transfusion (hemorrhage) syndrome\u306e1\u4f8b.\u3000\u7b2c35\u56de\u65e5\u672c\u5c0f\u5150\u75c5\u7406\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000(\u6771\u4eac\u30018\/29, 2015)<\/p>\n
21. \u9ed2\u5ca9\u9756\u6df3\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u4e2d\u6751\u3000\u6075\u7406\u5b50\u3001\u5bae\u5730\u3000\u5229\u660e\u3001\u798f\u898b\u3000\u30a2\u30a6\u30a7\u30a4\u30b9\u3001\u798f\u7530\u3000\u3055\u3068\u307f\u3001\u524d\u7530\u3000\u660c\u4e8c\u3001\u6728\u539f\u3000\u5eb7\u3001\u4eca\u6751\u3000\u5353\u90ce\u3001\u6d45\u7530\u3000\u7950\u58eb\u90ce\uff1a\u6df1\u90e8\u9759\u8108\u8840\u6813\u5185\u306eT1WI\u4f4e\u4fe1\u53f7\u304a\u3088\u3073T2WI\u7b49\u4fe1\u53f7\u306f\u5668\u8cea\u5316\u3092\u53cd\u6620\u3059\u308b\u3001 \u7b2c43\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff08\u6771\u4eac\u90fd\u30019\/9-9\/11\uff0c2015\uff09<\/p>\n
22. \u5c71\u4e0b\u3000\u7be4\u3001\u76db\u53e3\u6e05\u9999\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306e\u6975\u6027\u306b\u3088\u308b\u7d44\u7e54\u56e0\u5b50\u3068\u30d8\u30ad\u30bd\u30ad\u30ca\u30fc\u30bcII\u767a\u73fe\u3068\u89e3\u7cd6\u7cfb\u306e\u95a2\u4e0e\u3001\u7b2c20\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a\uff08\u5927\u962a\u300110\/17\uff09<\/p>\n
23. Hata M, Sugimoto T, Chuman H, Yano T, Sato Y. Extraocular muscle invasion adult T-cell leukemia\/lymphoma. 8th Asian Neuro-Ophthalmology Society Meeting, (Beijing, Oct 24, 2015)<\/p>\n
24. \u5c71\ufa11\u4e00\u8ad2\u3001\u5c71\u4e0b \u7be4\u3001\u8d99 \u82ab\u3001\u5fd7\u6c34\u967d\u4e00\u3001\u5ddd\u4e95\u6075\u4e00\u3001\u7389\u6728\u9577\u826f\u3001\u8d99\u677e\u5409\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u4e45\u4e0b\u88d5\u53f8: 14C-\u9162\u9178\u306e\u5bb6\u514e\u52d5\u8108\u786c\u5316\u75c5\u5909\u3078\u306e\u96c6\u7a4d\u6a5f\u5e8f\uff1a11C-\u9162\u9178\u306b\u3088\u308b\u52d5\u8108\u786c\u5316\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u305f\u3081\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u7b2c55\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u6771\u4eac, 11\/5-11\/7\uff09<\/p>\n
25. \u6749\u672c\u8cb4\u5b50\u3001\u4e2d\u99ac\u79c0\u6a39\u3001\u5f8c\u85e4\u6e05\u9999\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76f4\u4e95\u4fe1\u4e45\u3000\u5916\u773c\u7b4b\u6d78\u6f64\u3092\u8a8d\u3081\u305f\u6210\u4ebaT\u7d30\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b.\u3000 \u7b2c53\u56de\u65e5\u672c\u795e\u7d4c\u773c\u79d1\u5b66\u4f1a (\u3055\u3044\u305f\u307e\u300111\/6-7, 2015)<\/p>\n
26. \u5fb3\u6e80\u8cb4\u5b50\u3000\u91ce\u53e3\u88d5\u53f2\u3000\u5927\u91ce\u62db\u4f38\u3000\u5cf0\u677e\u6620\u5b50\u3000\u9ed2\u6728\u6804\u8f1d\u3000\u76db\u53e3\u6e05\u9999\u3000\u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u7b2c4\u8133\u5ba4\u306b\u767a\u751f\u3057\u305f\u30ed\u30bc\u30c3\u30c8\u5f62\u6210\u6027\u30b0\u30ea\u30a2\u795e\u7d4c\u7d30\u80de\u816b\u760d\u306e\uff11\u4f8b\u3001\u7b2c54\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a (\u540d\u53e4\u5c4b\u300111\/21-22, 2015)<\/p>\n
27. \u68ee\u3000\u667a\u5b50\u3001\u82b1\u725f\u79ae\u5bcc\u7f8e\u96c4\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u7a7f\u523a\u5438\u5f15\u7d30\u80de\u8a3a\u306b\u3066\u826f\u60aa\u6027\u306e\u9451\u5225\u304c\u56f0\u96e3\u3067\u3042\u3063\u305fDuctal carcinoma in situ \u306e1\u4f8b.\u3000\u7b2c54\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a\u3000(\u540d\u53e4\u5c4b\u300111\/21-22, 2015)<\/p>\n
28. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u9b4f\u5cfb\u6d38\u3001\u6751\u5ca1\u7d14\u8f14\u3001\u798f\u5cf6\u548c\u5b50\u3001\u9bab\u5cf6\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u60aa\u6027\u5ea6\u306e\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305fBrenner tumor\u306e1\u4f8b. \u7b2c43\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a (\u6771\u4eac\u300112\/20, 2015)<\/p>\n
\u25a0\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/p>\n
1. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u306b\u304a\u3051\u308b\u51dd\u56fa\u7cfb\u306e\u5f79\u5272\u3001\u7b2c44\u56de\u65e5\u672c\u5fc3\u8108\u7ba1\u4f5c\u52d5\u7269\u8cea\u5b66\u4f1a (\u9ad8\u677e\u30012\/6, 2015)<\/p>\n
2. Nozomi?Watanabe Yoshisato?Shibata, Keiichi?Ashikaga, Nehiro?Kuriyama, Yujiro?Asada\uff1aRole of Endomyocardial biopsy for the screening of secondary cardiomyopathy in the assessment of cardiac arrhythmias\u3000\u7b2c79\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u3000(\u5927\u962a\u30014\/25, 2015)<\/p>\n
3. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u52d5\u8108\u8840\u6813\u3068\u9759\u8108\u8840\u6813\u2010\u8840\u6813\u5f62\u6210\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u2010\u7b2c30\u56de\u65e5\u672c\u4e0d\u6574\u8108\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30fb\u7b2c32\u56de\u65e5\u672c\u5fc3\u96fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000(\u4eac\u90fd\u30017\/29, 2015)<\/p>\n
4. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u75c5\u7406\u50cf\u304b\u3089\u307f\u305f\u52d5\u9759\u8108\u8840\u6813\u306e\u5f62\u6210\u6a5f\u5e8f\u3001\u7b2c56\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a\u3000(\u6771\u4eac\u300110\/29, 2015)<\/p>\n
5. \u767d\u6ff1\u5e78\u751f\u3001\u8352\u6b66\u516b\u8d77\u3001\u6e05\u5c71\u548c\u662d\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6797\u900f\u3001\u6817\u6797\u5fe0\u4fe1\u3000LBC\u6cd5\u3092\u7528\u3044\u305f\u5b50\u5bae\u5185\u819c\u7d30\u80de\u8a3a\u306e\u691c\u8a0e.\u3000 \u7b2c54\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a\u3000(\u540d\u53e4\u5c4b\u300111\/21-22, 2015)<\/p>\n
\u25a0\u6559\u80b2\u8b1b\u6f14<\/p>\n
1. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u75c5\u7406\u50cf\u304b\u3089\u307f\u305f\u51a0\u52d5\u8108\u786c\u5316\u3068\u8840\u6813\u5f62\u6210\u3001\u7b2c15\u56de\u52d5\u8108\u786c\u5316\u6559\u80b2\u30d5\u30a9\u30fc\u30e9\u30e0 (\u5927\u962a\u30012\/8, 2015)<\/p>\n
2. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u75c5\u7406\u50cf\u304b\u3089\u307f\u308b\u52d5\u8108\u786c\u5316\u3068\u8840\u6813\u5f62\u6210\u3001\u7b2c56\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a \u8108\u7ba1\u5c02\u9580\u533b\u6559\u80b2\u30bb\u30c3\u30b7\u30e7\u30f3\u3000(\u6771\u4eac\u300110\/30, 2015)<\/p>\n
\u25a0\u53d7\u8cde<\/p>\n
1. Sameshima, N.\uff1aJournal of Atherosclerosis and Thrombosis Awards 2014<\/p>\n
\u25a0\u30b9\u30e9\u30a4\u30c9\u30b3\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9<\/p>\n
1. \u76db\u53e3\u6e05\u9999\uff1a\u80c3\u7c98\u819c\u4e0b\u816b\u760d (Adenocarcinoma arising from inverted hamartomatous polyp)\u3000\u7b2c343\u56de\uff08\u4f50\u8cc0\u770c\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u597d\u751f\u9928\u3001\u4f50\u8cc0\u5e02\uff09<\/p>\n
2. \u843d\u5408\u5f70\u5b50\uff1a\u5b50\u5bae\u981a\u90e8\u816b\u760d (Villoglandular adenocarcinoma+stratified mucin producing intraepithelial lesions)\u3000\u7b2c344\u56de\uff08\u770c\u7acb\u5ef6\u5ca1\u75c5\u9662\u3001\u5ef6\u5ca1\u5e02\uff09<\/p>\n
3. \u4e2d\u6751\u6075\u7406\u5b50\uff1a\u814e\u816b\u760d (Renal cell carcinoma, unclassified)\u3000\u7b2c347\u56de\uff08\u5bae\u5d0e\u5927\u5b66\u3001\u5bae\u5d0e\u5e02\uff09<\/p>\n
4. \u524d\u5ddd\u548c\u4e5f\uff1a\u8180\u80f1\u816b\u760d (Papillary urothelial neoplasm of low malignant potential)\u3000\u7b2c347\u56de\uff08\u5bae\u5d0e\u5927\u5b66\u3001\u5bae\u5d0e\u5e02\uff09<\/p>\n
5.\u3000\u9b4f\u5cfb\u6d38\uff1a\u5341\u4e8c\u6307\u8178\u816b\u760d (Gastric type adenocarcinoma with fundic gland differentiation)\u3000\u7b2c348\u56de\uff08\u516c\u76ca\u8ca1\u56e3\u6cd5\u4eba\u6148\u611b\u4f1a\u4eca\u6751\u75c5\u9662\u5206\u9662\u3001\u9e7f\u5150\u5cf6\u5e02\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"
\u25a0\u539f\u8457\u8ad6\u6587 1. Matsuo K, Akakabe Y, Kitamura Y, Shimoda Y, Ono K, Ueyama T, Matoba S, Yamada H, Hatakeyama K, Asada … Continue reading